The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Endo International PLC

Nasdaq: ENDP
Last

(U.S.) $7.72

Today's change-0.16 -2.03%
Updated October 20 4:00 PM EDT. Delayed by at least 15 minutes.
 

Endo International PLC

Nasdaq: ENDP
Last

(U.S.) $7.72

Today's change-0.16 -2.03%
Updated October 20 4:00 PM EDT. Delayed by at least 15 minutes.

Endo International PLC down (U.S.)$0.16

Endo International PLC closed sharply lower Friday, dropping (U.S.)$0.16 or 2.03% to (U.S.)$7.72. Over the last five days, shares have lost 5.51% and sit 4.32% above their 52-week low. This security has underperformed the S&P 500 by 82.66% during the last year.

Key company metrics

  • Open(U.S.) $7.88
  • Previous close(U.S.) $7.88
  • High(U.S.) $7.90
  • Low(U.S.) $7.65
  • Bid / Ask(U.S.) $7.23 / (U.S.) $7.79
  • YTD % change-53.13%
  • Volume3,101,745
  • Average volume (10-day)5,311,204
  • Average volume (1-month)5,128,824
  • Average volume (3-month)5,686,076
  • 52-week range(U.S.) $7.40 to (U.S.) $21.87
  • Beta0.56
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forward2.19×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$19.68
Updated October 20 4:00 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.25%Sector:HealthcareIndustry:Pharmaceuticals - Generic & Specialty

Latest Company News

View more News
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2017Q1/2017Q4/2016Q3/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016
Revenue8761,0381,242884
Total other revenue--------
Total revenue8761,0381,242884
Gross profit336369485327
Total cost of revenue539669757557
Total operating expense1,5141,1054,536920
Selling / general / administrative156177213187
Research & development41434645
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)7782163,521131
Other operating expenses, total--------
Operating income-638-67-3,295-36
Interest income (expense), net non-operating-123-113-113-113
Gain (loss) on sale of assets--------
Other--------
Income before tax-754-177-3,406-145
Income after tax-696-165-3,333-191
Income tax, total-57-12-7246
Net income-1,397-174-3,338-219
Total adjustments to net income--------
Net income before extra. items-696-165-3,333-191
Minority interest0000
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-696-165-3,333-191
Inc. avail. to common incl. extra. items-1,397-174-3,338-219
Diluted net income-1,397-174-3,338-219
Dilution adjustment--------
Diluted weighted average shares223223223223
Diluted EPS excluding extraordinary itemsvalue per share-3.12-0.74-14.96-0.86
Dividends per sharevalue per share0.000.00--0.00
Diluted normalized EPSvalue per share-0.78-0.05-4.58-0.45